Interview with Enrica Giorgetti, General Director, Farmindustria, Italy
Despite Italy being one of the most important pharmaceutical markets not only in Europe but also in the World, the industry remained quite stable for the last two years and…
SIFI is the leading Italian ophthalmic company, focused on eye care since its foundation in 1935.
SIFI designs, manufactures and markets innovative pharmaceutical products, surgical and medical devices.
SIFI’s mission is to provide ophthalmologists and their patients with a wide range of therapeutic solutions to treat the most common eye diseases.
Cutting-edge innovation, continuous development, a clear understanding of patients and caregivers needs, have shaped an extensive spectrum of eye care products, developed and marketed by SIFI main Italian and foreign branches.
Headquartered in Catania (Sicily), SIFI operates directly in Italy, Romania and Mexico with a staff of more than 330 people worldwide.
Since June 2015 SIFI is backed by 21 Investimenti, private equity firm founded by Alessandro Benetton, to support the company’s international expansion and portfolio development strategy.
For more information, please visit SIFI website www.sifigroup.com.
Despite Italy being one of the most important pharmaceutical markets not only in Europe but also in the World, the industry remained quite stable for the last two years and…
Grunenthal-Formenti relies on Formenti’s 60 years experience in Italy and is the result of the merger of both the German and Italian entities in 96. How would you describe the…
Having led a 26 years long career in Pfizer, you have been involved in a number of different countries including leading markets such as the US and Japan, but also…
You have worked in other countries such as the UK and the US with very large and significant pharmaceutical industries. What would you say is particular about the Italian pharmaceutical…
Since 1982, CNR has been the Italian public body which most contributed to the creation of inventions and innovations. What have been the main strategies behind such a success in…
Over more than 25 years, PAREXEL has expanded its global footprint through a combination of organic growth, alliances, and acquisitions. What was the rationale behind entering Italy in 1995 and…
Roche Italy is one of the companies which went through the most significant re-organization process in the country in the past three years- with important changes in both its marketing…
When you were appointed General Director of the Agenzia Italiana del Farmaco (AIFA) in 2007, the dedicated Investigation Commission highlighted the need for an in-depth reorganization of the Agency in…
“The ball is in the hands of the government,” according to Giorgio Foresti, general manager of Ratiopharm. “Once aware of the opportunities created by generics, politicians will have to make…
The pharmaceutical industry arose from science – and so did Italy’s knowledge based economy. Building on a reputation for innovation carved in the 15th century, when Leonardo Da Vinci, Michelangelo,…
Petrone group was created in 1965, based on your parents’ Carmine and Fernanda’s entrepreneurial spirit. They survived through times of challenges for Italian groups and maintained their independence. In your…
Scharper’s history in the Italian market begins in 1958, but the company as we see it today was really created in the mid nineties, when you founded La Farmochimica Italiana…
See our Cookie Privacy Policy Here
